Tempus and Eric Lefkofksy Provide Data Driven Cancer Treatment

In the Tech News Spy article “Tempus, Eric Lefkosky, and the Rise of Data-Enabled Precision Medicine”, Heidi Harris discusses the new venture for the serial entrepreneur, Eric Lefkofksy.

Mr. Lefkofksy had a personal experience with the inadequacies of the healthcare industry when his wife was diagnosed with breast cancer. He found that though the healthcare industry may be up to date in more trivial technology like electronic health records, it doesn’t provide doctors with the vital information they need to provide individualized treatment to cancer patients. Despite the overwhelming amount of patient data available, physicians didn’t have access to the technology that can interpret and make use of this copious amount of data.

Over 40% of adults will face the diagnosis in their lives, which the National Cancer Institute suggests was almost 14.5 million U.S. residents in 2014. The number of diagnosis will rise by 2024 to nearly 19 million. Through the new company he Co-founded called Tempus, Eric Lefkofksy hopes to be able to provide more precise medicine and treatment for these sufferers and what Eric knows.

Tempus combines the molecular data with a patient’s clinical data through a platform that analyzes the available information to create a personalized treatment plan. They not only provide detailed reports for the physicians with actionable information that can have huge implications for the treatment, but it also provides treatment validation. Through machine learning and automation as well as state of the art cell-culture technology, the physicians are able to test the therapies in synthetic models. By using genomic sequencing to understand each individual’s tumor, they are able to provide individualized treatment plans and more information click here.

Eric Lefkofksy is an influential figure in Chigago’s community. He is on the board of directors for the The Art Institute of Chicago and the Children’s Memorial Hospital. He is also a dedicated philanthropist. He and his wife are both members of the Giving Pledge which seeks to inspire the elite to donate the majority of their wealth to charitable causes. He is founded the Lefkofksy Foundation with his wife to support educational, scientific and other charitable causes around the world.

Mr. Lefkofksy is also well known as the Co-Founder of a variety of companies such as Uptake, Groupon, Mediaocean, and Mediabank and Eric’s lacrosse camp.

Bradesco Is The Brazilian Bank And Luíz Carlos Trabuco Cappi Is The CEO Wall Street Likes In 2017

Banco Bradesco is a profit machine. The bank’s profit is up by almost 30 percent in the first half of 2017. Wall Street analysts are pushing Bradesco stock like it is the new Microsoft. That may be a slight exaggeration, but it is true. Bradesco is making investors look at Brazil again, and one of the main reasons Bradesco is so attractive is the bank’s CEO.

Luíz Carlos Trabuco Cappi is the bank’s fourth president and CEO, and he is one of the people who make the bank so special. Trabuco is not afraid to take a risk like the 2015 acquisition of the Brazilian division of HSBC. That deal was a big money transaction, but it put Bradesco in the running for the title of the largest private bank in Brazil.

Luíz Carlos Trabuco Cappi is not a typical Brazilian banker. He is a people’s banker as well as a knowledgeable businessman. Trabuco is from Marilia, a small town in the State of São Paulo. He is a loyal Bradesco employee with almost 40 years of service. Before becoming CEO, Trabuco was a director and vice-president of the bank. He was also the president of the bank’s insurance division, Banco Seguros. Seguros was a major profit center for the bank thanks to Trabuco’s leadership.

Mr. Trabuco is the current President-Director of the Bradesco’s organization companies. And he is Vice-Chairman of the Board of Directors of Banco Bradesco. He is the current Chairman of the Board of Directors of Elo Participações. Plus, he serves on the Strategic Committee of Vale. Luiz is also a member of the Board of Directors of Brazilian Federation of Banks. But Trabuco also sits on the Executive Board of the National Confederation of Financial Institutions.

When Bradesco was talking with HSBC’s Brazilian division in 2015, Trabuco’s banking knowledge and intuition helped to close the deal. Bradesco is on track to be the best private bank in Brazil, and Wall Street knows it. Bradesco’s stock is hot right now. Brazil needs foreign investors, and Bradesco is attracting investors from all over the world. First and second quarter profits hit an all-time high in 2017, and the bank is on track to have another record-breaking profit year. Luíz Carlos Trabuco Cappi is the person who steers the Bradesco ship through the muddy economic waters in Brazil, and he is doing what all good bankers do. He is making money for investors.

Learn more about LUiz Carlos Trabuco Cappi: http://www.tostoadv.com/bradesco-quer-mudar-regra-para-trabuco-ficar-no-cargo/

The Rise of Data-enabled Precision Medicine courtesy of Eric Lefkofsky

Despite the recent progress made in the health department through the development of electronic health records, a gap still exists between data collection and the utilization of the collected information in designing appropriate treatment procedures for the patient. Having realized about this gap, Eric Lefkofsky co-founded Tempus, a company that links clinical records and molecular data thereby improving the manner in which cancer care is delivered.

Initially, analytical software existed but there was an issue with reliable and accessible medical and clinical data and this acted as a hindrance to substantial progress in the development of effective cancer treatment medicine and programs. Tempus has overcome the barrier by developing software which has the capabilities of optical character recognition as well as natural language processing. Data from the field and in notes form can consequently be transformed into structured data which would be of assistant in the advancement of cancer care.

When it comes to the usage of molecular data, Tempus has made substantial steps in the advancement of science and technology via the use of human genome sequencing to gather information at lower costs. The information derived from human genes is used to develop medicines able to fight cancer in the molecular and cellular levels. The genes from humans have important clues on the effective ways of fighting diseases, and Tempus actualizes the derivation of such information and learn more about Eric.

Eric Lefkofsky is one of the most influential figures in the technological realm with his contributions significantly impacting the health sector among other areas. He is the CEO and co founder of Tempus, a company making a significant contribution in cancer treatment, as well as Groupon which is a market for e-commerce. He also co-founded Uptake Technologies, an entity that deals in designing analytical software and platforms.

Drawing from his major contributions in the technological universe, Eric Lefkofsky is an exemplary entrepreneur as well as a visionary on the maximization of technological advancements. His determination on solving common issues in the society through the use of technology led to his significant achievements more so in the usage of artificial intelligence as well as big data in improving the health care system. His continuous interest in charity, as well as his diligence in cancer treatment solutions makes him an exemplary leader and a mentor for many and read full article.

More Visit: https://www.tempus.com/about-us/

Market America CEO Leads Industry

J.R. Ridinger, Founder, Chairman, and Chief Executive Officer of Market America, was born in New Jersey and created his flagship company in 1992. While he has overseen the rapid growth of Market America, particularly so with the ever increasing capabilities of the internet, he is also the head of Shop.com. Under his watch, Market America has expanded into an international company, operating in nine countries across the globe and bringing in close to $1 billion in sales annually.

Since Mr. Ridinger’s initial foray into the business world, he has held true to a people-first approach that has permeated his business model and shifted the way that people across the world shop. Always the forward thinker, Mr. Ridinger foresaw the capabilities of the personal computer very early in the life of the computer age, tracing his plans back to 1984. During the early 80’s, computers were used mostly by very large companies, and even then, they were used to perform simple tasks that would pale in comparison to the duties we assign to computers today. It was during this time that Mr. Ridinger proclaimed that eventually, people would use computers to access nearly every avenue of their lives, utilizing their collective buying power, via the internet, to dictate the manner in which the consumer market flows. The Market America CEO’s ability to see market trends well into the future has allowed Market America and Shop.com rise comfortably into the stratosphere, making a myriad of individual millionaires on the way.

https://www.glassdoor.com/Reviews/Market-America-Reviews-E27063.htm

https://twitter.com/marketamerica?lang=en